FOXP3 and cancer: Combined with two previous studies [34], [35], which showed that gastric or ovarian cancer cells could induce the conversion of CD4+CD25− T cells into CD4+FoxP3+ Treg in vitro, we thought that most cancer cells might have the ability of the induction of Treg.